111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
47.77%
Revenue growth above 1.5x CX's 8.62%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
103.38%
Gross profit growth above 1.5x CX's 16.11%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
6432.14%
EBIT growth above 1.5x CX's 43.28%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
6432.14%
Operating income growth above 1.5x CX's 43.28%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
1018.10%
Positive net income growth while CX is negative. John Neff might see a big relative performance advantage.
1081.25%
Positive EPS growth while CX is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
1075.00%
Positive diluted EPS growth while CX is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.33%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.66%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-36.31%
Dividend reduction while CX stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
309.39%
OCF growth under 50% of CX's 2669.01%. Michael Burry might suspect questionable revenue recognition or rising costs.
171.54%
FCF growth 50-75% of CX's 246.02%. Martin Whitman would see if structural disadvantages exist in generating free cash.
24.81%
10Y revenue/share CAGR above 1.5x CX's 4.08%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
No Data
No Data available this quarter, please select a different quarter.
-16.11%
Negative 3Y CAGR while CX stands at 18.91%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
733.85%
Positive long-term OCF/share growth while CX is negative. John Neff would see a structural advantage in sustained cash generation.
No Data
No Data available this quarter, please select a different quarter.
8.99%
3Y OCF/share CAGR under 50% of CX's 789.52%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
3001.72%
Net income/share CAGR above 1.5x CX's 191.65% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
No Data
No Data available this quarter, please select a different quarter.
112.60%
Positive short-term CAGR while CX is negative. John Neff would see a clear advantage in near-term profit trajectory.
140.48%
10Y equity/share CAGR above 1.5x CX's 8.16%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
No Data
No Data available this quarter, please select a different quarter.
22.38%
3Y equity/share CAGR 1.25-1.5x CX's 20.32%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
114.32%
Dividend/share CAGR of 114.32% while CX is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
No Data
No Data available this quarter, please select a different quarter.
-25.28%
Negative near-term dividend growth while CX invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
22.82%
AR growth well above CX's 2.42%. Michael Burry fears inflated revenue or higher default risk in the near future.
-2.27%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
3.82%
Positive asset growth while CX is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
3.77%
BV/share growth above 1.5x CX's 0.06%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
3.16%
We have some new debt while CX reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
9.01%
SG&A growth well above CX's 2.18%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.